Antiporte, Julito F.

HRN: 23-86-81  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2026
CEFTRIAXONE 1G (VIAL)
06/24/2026
06/30/2026
IV
2g
OD
Cholecystitis
Checking Initial Appropriateness 
06/24/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/24/2026
06/30/2026
IV
500mg
Q8
Cholecystitis
Checking Initial Appropriateness 
07/02/2026
CEFTRIAXONE 1G (VIAL)
07/02/2026
07/09/2026
IV
2g
OD
Intraabdominal Infection
Remove - Pending Acceptance
07/02/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/02/2026
07/09/2026
IV
500mg
Q8
Intraabdominal Infection
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: